جست‌وجوی استاد و پژوهشگر

Patrick M. Tarwaterمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• Traumatic Brain Injury Rehabilitation and Sleep
• Biostatistical Methods in Comparative Pathobiology
• +۱ مورد دیگر

Patrick M. Tarwater is a Professor in the Department of Epidemiology & Biostatistics at Texas A&M University, with research spanning infectious disease epidemiology, traumatic brain injury rehabilitation, sleep science, biostatistical methods, and environmental health impacts on child development. His work integrates clinical, laboratory, and computational approaches to address complex public health challenges. His educational foundation includes: PhD in Biometry from University of Texas Health Science Center at Houston (1999) MS in Mathematics from Texas Tech University (1992) BA in Mathematics from Texas Tech University (1990) Tarwater's research in Infectious Disease Epidemiology features extensive work on HIV/SIV pathogenesis using non-human primate models, SARS-CoV-2 variant dynamics, and microbial risk assessment in environmental settings. His Traumatic Brain Injury and Sleep research includes innovative interventions like the OSABI sleep hygiene protocol and objective sleep monitoring methodologies for rehabilitation patients. The Environmental Health focus centers on the ECHO program's investigation of maternal nutrition and child health outcomes, alongside risk assessments for oil spill contaminants and recreational water safety. Analysis of his 2018-2024 publications reveals three dominant trajectories: (1) viral pathogenesis mechanisms using advanced animal models, (2) neuroimmunological consequences of infections and injuries, and (3) environmental exposure risk modeling. His work consistently employs sophisticated biostatistical techniques and translational approaches bridging laboratory findings to clinical applications. While no specific awards are documented in the source material, Tarwater's prolific publication record in high-impact journals demonstrates significant scholarly contributions. His teaching portfolio includes foundational courses in epidemiology and biostatistics, plus advanced instruction in cohort analysis and epidemiologic inference.

• Oral Microbiology
• Biofilm Biology
• Antimicrobial Nano-Technology
• +۴ مورد دیگر

Dr. Peter Zilm is an Associate Professor in the Adelaide Dental School at the University of Adelaide, part of the Faculty of Health and Medical Sciences. His research focuses on bacterial biofilm dynamics, particularly in oral pathogens linked to caries and periodontal disease, and their systemic implications. Key projects include developing oral microbiome transplantation therapies and pH-responsive 'intelligent particles' as antimicrobial agents. Collaborations with chemical engineers and industry aim to advance nano-technological solutions for dental applications. Research interests span biofilm inhibition mechanisms, the gut microbiome's role in gastrointestinal inflammation triggered by periodontitis, and the development of novel antimicrobial coatings for medical devices. His work integrates advanced technologies like cellular impedance (exCELLigence) and next-generation sequencing. He has secured NHMRC funding (2020-25) for oral microbiome transplantation research. Projects are based at the Helen Mayo South Building and involve collaborations with institutions in Spain, the UK, and elsewhere. Dr. Zilm supervises Honours, Masters, and PhD students across multiple translational projects, including anti-biofilm agents, oral microbiome transplantation efficacy, and the relationship between oral bacteria and systemic diseases like cardiovascular issues and cancer. His recent publications highlight innovations in nano-technology, biofilm disruption, and probiotic interventions for periodontal disease.

Heli Simojokiمشاهده پروفایل

استاد

• Veterinary Science
• Bovine Medicine
• Animal Health
• +۳ مورد دیگر

Heli Simojoki is a Professor at the Faculty of Veterinary Medicine, University of Helsinki, in the Department of Production Animal Medicine. She is affiliated with the Helsinki One Health research organization. Her research focuses on bovine medicine, particularly infectious diseases in livestock, mastitis, and cattle health management. Key research interests include bacterial pathogens (e.g., Fusobacterium necrophorum , Mycoplasma bovis ), vaccination efficacy, antibiotic use in dairy herds, and hoof health (e.g., digital dermatitis and interdigital phlegmon). She has supervised multiple PhD students, including Aino Riihimäki and Atte Sandelin. Her recent publications (2021–2025) address genomic analysis of pathogens, vaccination impacts, and management practices to reduce morbidity and antibiotic usage. She has been involved in projects funded by the Academy of Finland and industry partners like HKScan and Valio. Professional activities include peer reviewing for journals like Journal of Dairy Science and Acta Veterinaria Scandinavica , and contributing to policy discussions on animal welfare (e.g., Ministry of Agriculture and Forestry consultations).

Chia Leeمشاهده پروفایل

استاد

• Microbiology
• Immunology
• Bacterial Pathogenesis
• +۳ مورد دیگر

Chia Lee, Ph.D., is a Professor in the Department of Microbiology and Immunology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. Their research focuses on understanding the molecular mechanisms of Staphylococcus aureus pathogenesis, particularly the regulation of virulence factors such as capsule and α-toxin. They completed their Ph.D. and postdoctoral training at Kansas State University. Key research interests include bacterial virulence regulation, antibiotic resistance, biofilm formation, and the transition from carriage to invasive disease. Their lab employs structural biology, mutagenesis, and proteomics to study regulatory networks like ClpC, SigB, and small RNAs. Recent work involves developing rat models for studying implant-associated biofilm infections. Publications highlight advances in understanding capsule regulation via SarZ, MgrA, and RbsR, as well as α-toxin regulation and biofilm matrix composition. Collaborators include M. G. Lei, R. K. Gupta, and D. D. Gudeta. Research has implications for developing novel therapeutics against staphylococcal infections. Lab activities emphasize translational research bridging basic science and clinical applications, with a focus on elucidating how regulatory pathways control virulence expression during infection. Current projects address in vivo regulatory dynamics and disease transition mechanisms.

Ignacio Mir-Sanchisمشاهده پروفایل

استادیار

• Antimicrobial Resistance
• Phage Therapy
• Mobile Genetic Elements
• +۴ مورد دیگر

Ignacio Mir-Sanchis serves as Assistant Professor at Umeå University's Department of Medical Biochemistry and Biophysics and holds an affiliated position at the Wallenberg Centre for Molecular Medicine (WCMM). His research focuses on antimicrobial resistance mechanisms and phage therapy development. His primary research interests center on Mobile Genetic Elements (MGEs) in Staphylococcus aureus , particularly Methicillin-Resistant S. aureus (MRSA). His laboratory investigates how MGEs hijack host proteins for DNA replication and gene expression during horizontal transfer, identifying potential drug targets. Additional work explores bacteriophages as therapeutic tools against antibiotic-resistant infections, employing techniques from molecular biology to cryo-EM structural analysis. Recent publications reveal significant trends in bacterial defense mechanisms against viruses and protein dynamics related to antibiotic resistance spread. His 2025 discovery of bacterial viral defense systems provides new pathways for combating resistance. WCMM Fellow (2019) Swedish Research Council Grant (2023) As head of the Mir-Sanchis Lab, he leads research on antimicrobial resistance and phage therapy, with active projects in bacteriophage engineering for therapeutic applications and structural analysis of resistance mechanisms. Current work includes developing phage-like particles as biotechnology tools and investigating host protein hijacking by MGEs.

Mark Smeltzerمشاهده پروفایل

استاد

• Bacterial Pathogenesis
• Antimicrobial Resistance
• Infectious Disease
• +۴ مورد دیگر

Mark Smeltzer is a Professor in the Department of Microbiology and Immunology and Department of Orthopaedics at the University of Arkansas for Medical Sciences (UAMS). He specializes in the molecular pathogenesis of Staphylococcus aureus infections, particularly focusing on its role in orthopaedic infections, biofilm formation, and antibiotic resistance mechanisms. His work integrates molecular biology, proteomics, and nanotechnology to develop novel therapeutic strategies. Dr. Smeltzer earned his Ph.D. from Kansas State University and completed postdoctoral training under Dr. John J. Iandolo. His research is supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), the Congressionally-Directed Medical Research Program, and the Texas Hip and Knee Foundation. Key collaborations include projects with Dr. Jingyi Chen (nanotherapeutics) and Dr. Alexandru Biris (bone regeneration scaffolds). Research Interests: Mechanisms of S. aureus biofilm formation and antibiotic resistance Role of the sarA regulatory gene in virulence and infection Development of nanoparticle-based therapies for biofilm-associated infections Orthopaedic device-related infections and bone regeneration Key Findings: Identified sarA mutations limiting biofilm formation and enhancing antibiotic susceptibility Developed gold nanocage-based systems for targeted antibiotic delivery and photothermal therapy Discovered protease-dependent virulence factors critical for infection progression Funding Highlights: NIAID grants for sarA regulatory pathway studies Congressionally-Directed Medical Research Program grants for small molecule inhibitors Collaborative grants for nanotherapeutic and bone regeneration projects Dr. Smeltzer’s lab actively explores translational approaches to combat antibiotic-resistant infections, with a focus on clinical applications in orthopaedics and infectious diseases.

• Microbiology
• Infection Biology
• Immunology
• +۳ مورد دیگر

Prof. Friedrich Götz is a Senior Professor and Head of the Department of Microbial Genetics at the University of Tübingen, Germany. He has held this position since 2015, following his tenure as a full professor from 1987 to 2015. He is also a Visiting Professor at the Shiraz University of Medical Sciences (SUMS, 2020–present) and a member of the Cluster of Excellence - CMFI (2018–present). His academic journey includes a Ph.D. in Microbiology from Ludwig Maximilians University (LMU) Munich (1974–1978) and Habilitation at TU Munich (1985). His research focuses on microbial genetics, particularly the physiology of staphylococci, lipoprotein roles in immune responses, and bacterial-host interactions. Recent studies highlight microbiota-derived neurotransmitters influencing host cells and the development of novel antimicrobial compounds. His work has led to groundbreaking insights into skin microbiota's role in wound healing and neurochemical signaling. Prof. Götz has been awarded the DECHEMA Award (1989), DGHM Award (1991), and DGHM Lecturer Award (2009). He has served as President and Vice President of the VAAM (2003–2009), and has held leadership roles in major initiatives, including the DFG Graduate College 685 (2010–2011) and the Transregio SFB (2006–2013). He actively contributes to scientific publishing as an editor for journals like Molecular Microbiology and Medical Microbiology and Immunology, and advises international research institutions. His research spans over 380 peer-reviewed publications, with an h-index of 99, and has mentored over 120 PhD students and postdocs, many of whom have become professors. His lab, part of the Interfaculty Institute for Microbiology and Infection Medicine (IMIT), collaborates globally on microbial genetics and infection biology.

Mohamed Fakhrمشاهده پروفایل

استاد

• Molecular microbiology
• Foodborne bacterial pathogens
• Antimicrobial resistance
• +۷ مورد دیگر

Mohamed K. Fakhr, Ph.D., is a full-time Professor in the Department of Biological Sciences at The University of Tulsa, affiliated with the Oxley College of Health Sciences. His research focuses on molecular microbiology of foodborne pathogens, particularly Campylobacter and Staphylococcus aureus, examining antibiotic resistance mechanisms, plasmid characterization, and survival under extreme conditions. Ph.D., Oklahoma State University M.Sc., Zagazig University, Benha Branch B.Sc., Zagazig University, Benha Branch Research interests include: Molecular microbiology of foodborne pathogens Antimicrobial and heavy metal resistance Plasmid-mediated survival mechanisms Genomics and transcriptomics approaches Diversity of extremophilic actinomycetes Antimicrobial and antitumor metabolites His 2025 Google Scholar publications highlight advancements in Campylobacter aerotolerance, plasmid genomics, and extremophile metabolite discovery. Notable trends span food safety, bacterial stress response, and molecular typing methodologies. Scientific awards include: 2025 UTulsa Outstanding Teacher Award 2025 UTulsa Oxley College Teaching Excellence Award Dr. Fakhr's lab investigates polymicrobial interactions in retail meats, utilizes next-generation sequencing for plasmid analysis, and explores actinomycetes in extreme environments. His work bridges molecular biology and public health through pathogen characterization and teaching excellence.

• Phage Therapy
• Microbiome Engineering
• Bacteriophage-Bacteria Interactions
• +۳ مورد دیگر

Mohammadali Khan Mirzaei serves as Vice Head of Research Unit and Team Leader at the Institute of Virology, Helmholtz Zentrum München and Technical University of Munich since May 2022. Previously held Senior Postdoctoral Researcher (2019-2022) and Postdoctoral Researcher (2016-2019) positions at the same institutions and McGill University respectively. His research focuses on phage-host interactions for developing therapeutics against drug-resistant infections and microbiome engineering. Utilizes Single-cell techniques Multi-omics approaches Metabolic labeling Advanced model systems to investigate bacteriophage applications in human health contexts including gut microbiota modulation and inflammatory diseases. Recent publications demonstrate strong emphasis on phage therapy translation , with key contributions in ulcerative colitis treatment, microbiome westernization effects on cancer risk, and novel phage preservation technologies. Research bridges fundamental virology with clinical applications targeting multi-drug resistant pathogens. Academic trajectory includes Ph.D. in Molecular Genetics from Stockholm University (2016) with thesis on "The efficacy of bacterial viruses against multi-resistant Escherichia coli: from isolation to Pharmacology" , following M.Sc. research on phage isolation against resistant E. coli strains.

Vivek Jainمشاهده پروفایل

استاد

• HIV/AIDS
• Infectious Diseases
• Implementation Science
• +۵ مورد دیگر

Dr. Vivek Jain is a Professor of Medicine and Infectious Diseases at the University of California, San Francisco (UCSF), affiliated with San Francisco General Hospital. He leads the Infectious Diseases Clinic, oversees SFGH’s Infection Control and Prevention Team, and directs outpatient therapies for HIV and COVID-19. His research focuses on HIV antiretroviral therapy (ART) in resource-limited settings, implementation science, and global health. He co-directs the SEARCH Study, a large-scale HIV testing and treatment initiative in East Africa, and has contributed to landmark trials like EARLI and RAPID-VL. Education: B.A. Biochemistry, Harvard University (1998) M.D., Stanford University School of Medicine (2003) UCSF Residency/Chief Residency in Internal Medicine (2006–2007) Infectious Diseases Fellowship, UCSF (2009) M.A.S. in Clinical Research, UCSF (2010) Research Interests: Dr. Jain’s work bridges clinical practice and global health, emphasizing early ART initiation, HIV viral load monitoring, and pandemic response strategies. His studies address challenges in Sub-Saharan Africa, including streamlined care delivery and hypertension integration. He also investigates SARS-CoV-2 epidemiology and telemedicine applications for infectious diseases. Publications: His 150+ publications span HIV pathogenesis, implementation science, and pandemic preparedness. Key themes include CD4+ T-cell dynamics in HIV, population-level viral suppression, and racial disparities in vaccine uptake. Awards: Fellow of the Infectious Diseases Society of America (FIDSA) Grants & Teams: Recipient of CDC and Gilead Sciences funding for studies like RAPID-VL (optimizing HIV viral load monitoring). Collaborates with institutions in Uganda/Kenya, including Makerere University and the Infectious Diseases Research Collaboration (IDRC). Labs/Teams: Leads the SEARCH Study and RAPID-VL Trial teams, focusing on scalable HIV interventions and pandemic response strategies in low-resource settings.

Jessica Sheldonمشاهده پروفایل

استادیار

• Bacterial Pathogenesis
• Host-Pathogen Interactions
• Molecular Genetics
• +۵ مورد دیگر

Jessica Sheldon is an Assistant Professor in the Department of Biochemistry, Microbiology & Immunology at the University of Saskatchewan's College of Medicine. She joined the university in 2022 after completing postdoctoral training at Vanderbilt University Medical Center under the mentorship of Dr. Eric Skaar. Her educational background includes: PhD in Microbiology and Immunology (2015) from the University of Western Ontario MSc in Biology (2009) from Lakehead University HBSc in Biology (2006) from Lakehead University Dr. Sheldon's research focuses on the molecular pathogenesis of multidrug resistant bacteria, particularly Acinetobacter baumannii. Her work investigates the tug of war between host nutritional immunity and bacterial nutrient acquisition strategies. She examines how pathogens overcome host-imposed nutrient limitations, with special attention to metal ion homeostasis and iron acquisition mechanisms. Her laboratory employs techniques in bacteriology, molecular genetics, transcriptomics, and infection modeling to identify virulence mechanisms. Her publication record demonstrates consistent expertise in bacterial iron acquisition and host-pathogen interactions, with recent work increasingly focused on Acinetobacter baumannii's evasion of nutritional immunity during infection. The trajectory of her research shows progression from fundamental studies of iron acquisition in Staphylococcus aureus to translational work on a WHO-designated priority pathogen. Dr. Sheldon has established an active research program on multidrug resistant bacterial pathogens, with particular emphasis on understanding the molecular mechanisms that enable pathogens like Acinetobacter baumannii to overcome host defenses. Her work has significant implications for developing novel therapeutic strategies against antibiotic-resistant infections.

Romney M. Humphriesمشاهده پروفایل

استاد

• Antimicrobial resistance
• Bacterial pathogenesis
• Diagnostic testing
• +۱ مورد دیگر

Romney M. Humphries, Ph.D., D(ABMM), M(ASCP), is a Professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, serving as Medical Director of the Microbiology Laboratory. Their research focuses on advancing diagnostic technologies for antibiotic-resistant infections and studying real-time evolution of antimicrobial resistance mechanisms. Academic Rank: Professor Department: Pathology, Microbiology, and Immunology Key research areas include antimicrobial resistance , diagnostic innovation , and clinical microbiology . The Humphries laboratory specializes in evaluating rapid identification methods for multidrug-resistant pathogens and novel antimicrobial development. Recent publications highlight advancements in MALDI-TOF MS, CRISPR diagnostics, and regulatory frameworks for laboratory-developed tests. Scientific contributions appear in journals such as New England Journal of Medicine , Clinical Infectious Diseases , and Journal of Clinical Microbiology . Current work emphasizes integrating genotypic/phenotypic testing for improved patient outcomes and informing federal policies on diagnostic standardization.

• Computational Immunology
• Structural Biology
• Molecular Docking
• +۳ مورد دیگر

Dinler A. Antunes is an Assistant Professor of Computational Biology at the Department of Biology and Biochemistry of the University of Houston, where he is also a member of the Center for Nuclear Receptors and Cell Signaling (CNRCS). His research focuses on computational immunology and structural modeling of protein-ligand complexes that play key roles in cellular immunity. Dr. Antunes received his educational training at the Federal University of Rio Grande do Sul (UFRGS) in Brazil, earning a Bachelor's degree in Biomedicine in 2008, a Master's degree in Genetics and Molecular Biology in 2011, and a Doctorate in 2014. He later completed postdoctoral studies at Rice University's Computer Science Department with a fellowship from the Computational Cancer Biology Training Program (CCBTP), collaborating with MD Anderson Cancer Center. His research interests center on developing computational methods for structural modeling of peptide-MHC complexes, with applications in personalized cancer immunotherapy and vaccine development. Dr. Antunes has pioneered several computational tools including DockTope, DINC, APE-Gen, and HLA-Arena, which enable researchers to model and analyze peptide-HLA complexes for immunotherapy applications. His work addresses the challenge of protein flexibility in molecular docking, particularly for large ligands like peptides binding to MHC receptors. Analysis of Dr. Antunes' recent publications (2023-2025) reveals a strong focus on computational immunology, with particular emphasis on peptide-MHC structural modeling, T-cell cross-reactivity prediction, and applications in cancer immunotherapy. His work spans structural biology, machine learning applications in immunology, and translational research connecting computational predictions with clinical applications, particularly in acute myeloid leukemia and rheumatoid arthritis. Dr. Antunes has received several scientific awards and recognitions: SCI Gold Oral Presentation Award at the 6th Annual SCI Summer Research Colloquium 2020 Immuno-Oncology Young Investigators' Forum (IOYIF) PhD Postdoc Awards Selected to represent the CCBTP program during the 30th Annual Keck Research Conference Fellowship from the Computational Cancer Biology Training Program Dr. Antunes is actively recruiting PhD students and postdoctoral researchers to join his team at the University of Houston. His laboratory develops computational tools for structural immunology, with current projects including HLA-Arena (a customizable environment for peptide-HLA complex analysis), DINC-COVID (a webserver for ensemble docking with SARS-CoV-2 proteins), and CrossTope (a structural database for cross-reactivity assessment).

• Microbial Sciences
• Infectious Diseases
• Antimicrobial Resistance
• +۲ مورد دیگر

Julie Morrissey is Professor and Director of Leicester Microbial Sciences and Infectious Disease Research Centre at the University of Leicester. Her research focuses on bacterial pathogenesis, antimicrobial resistance, and environmental impacts on infection. Research examines Staphylococcus aureus adaptation to air pollution, microbiome dysbiosis in COPD, and novel antimicrobial strategies. Work bridges microbiology, environmental science, and clinical applications.

• Orthopaedic Oncology
• Musculoskeletal Tumors
• Sarcoma Care
• +۲ مورد دیگر

Dr. Michelle Ghert is a Professor in the Department of Orthopaedics at the University of Maryland School of Medicine , with a distinguished career in orthopaedic oncology . She completed her residency at Duke University and fellowship at University of Toronto , and previously held academic appointments at McMaster University from 2005–2017 before joining Maryland in 2024. Education : B.A.S. from Stanford University (1992), MD from Vanderbilt University (1996) Leadership : Principal investigator in international trials like PARITY and SAFETY , shaping sarcoma care standards Her research focuses on musculoskeletal tumor management and complex limb reconstruction , with expertise in randomized controlled trials for surgical and oncology protocols. She has received prestigious awards including the 2023 Kappa Delta Ann Doner Vaughan Award and 2019 J. Édouard Samson Award , and holds active grants from NIH , DOD , and the Canadian Cancer Society .